Startups
Edit
American Headache Society
https://headachejournal.onlinelibrary.wiley.com/Last activity: 17.05.2023
Active
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 30, 2022 | Underweight, Obesity May Increase Risk for Migraine | TUESDAY, Aug. 30, 2022 (HealthDay News) -- Underweight and obesity are associated with increased migraine risk, according to a review published in the July/August issue of Headache: The Journal of Head and Face Pain. Fahimeh Martami, Ph.D.,... |
| Aug 29, 2022 | Israeli startup Theranica, maker of migraine-zapping device, nabs $45m investment Into the Land: The Forgery Scandal | Israeli startup Theranica, the developer of a medical device to treat acute migraines, has pulled in a new investment of $45 million for an ongoing Series C round the company plans to finalize in the fall. The investment was led by Philadel... |
| Jul 1, 2022 | Patients With Migraine Have Balance Impairment | FRIDAY, July 1, 2022 (HealthDay News) -- Patients with migraine have balance impairment, which is associated with fear of falls, dizziness disability, and kinesiophobia, according to a study published online May 20 in Headache. Gabriela F. ... |
| Jun 29, 2022 | Neurolief Announces Publication of the RIME Pivotal Study for Relivion MG – a Digital Therapeutics Platform for Migraine | Results of clinical study demonstrate non-invasive combined occipital and trigeminal neuromodulation system may offer pronounced benefit for migraine patients. TAMPA, FL, UNITED STATES, June 29, 2022 /EINPresswire.com/ -- Neurolief, a neuro... |
| Sep 3, 2021 | Impel NeuroPharma’s drug-device combo product nabs FDA nod for migraine | Impel NeuroPharma’s new take on delivering an old migraine drug won FDA approval Friday, giving patients a faster-acting way to respond to debilitating migraine attacks. The Impel product, Trudhesa, is a nasal spray formulation of the migra... |
| Aug 16, 2021 | Psychedelic mushrooms to treat rare headache: Oxford startup lands $80M | Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, today announced it has successfully completed an oversubscribed Series B financing, ra... |
| May 18, 2021 | IMPEL NEUROPHARMA, INC. Impel NeuroPharma Launches Reroute Migraine Relief, Educational Initiative That Brings to Life the Underrecognized Connection Between Migraine, the Brain and Gut | SEATTLE, May 18, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma (Nasdaq: IMPL), a late-stage biopharmaceutical company, today launched Reroute Migraine Relief, an educational initiative which aims to raise awareness of the complexities of migra... |
| Jan 29, 2020 | Satsuma Pharmaceuticals Publishes Phase 1 Trial Results | SOUTH SAN FRANCISCO, California (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today announced that Phase 1 trial results detailing pharmacokinetics (PK), tolerability, and safet... |
| Pre-TBI Headache Affects Diagnosis of Posttraumatic Headache | WEDNESDAY, June 29, 2022 (HealthDay News) -- Individuals with headache before traumatic brain injury (TBI) are less likely to receive a diagnosis of posttraumatic headache (PTH), according to a study published online May 20 in Headache. Zac... |
Show more
Reviews 0
FAQ about American Headache Society
What has the press written about American Headache Society?
Parsers VC has collected 13 articles mentioning American Headache Society, among them “Underweight, Obesity May Increase Risk for Migraine” (Aug 30, 2022) and “Israeli startup Theranica, maker of migraine-zapping device, nabs $45m investment Into the Land: The Forgery Scandal” (Aug 29, 2022).
Is American Headache Society still active?
Yes, American Headache Society is active; its latest activity on Parsers VC dates from May 17, 2023.